3-methylhistidine and clinical outcomes in maintenance haemodialysis patients.

Emilie BresCécile PaganAnaïs BoucharaMyriam PasturalSamuel GranjonMaurice LavilleDenis FouqueChristophe O SoulageLaetitia Koppe

Published in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2022)

Elevated serum 3-MH concentration appears to be a marker of better lean tissue mass and nutritional status. Low serum 3-MH is a robust and independent predictor of CV events in the MHD population.

Keyphrases

end stage renal disease
chronic kidney disease
peritoneal dialysis
ejection fraction
newly diagnosed
prognostic factors
patient reported outcomes
body composition